TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T43739	Voltage-gated sodium channel alpha Nav1.8	B5SDK6	1-[3-[2-Fluoro-3-(trifluoromethoxy)phenyl]phenyl]pyrazole-3,5-dicarboxamide	Investigative	53321262	C18H12F4N4O3	408.3	C1=CC(=CC(=C1)N2C(=CC(=N2)C(=O)N)C(=O)N)C3=C(C(=CC=C3)OC(F)(F)F)F	IC50 = 1513000 nM	Non binder
T43739	Voltage-gated sodium channel alpha Nav1.8	BH5NW1	1-[3-[2,5-Bis(trifluoromethyl)phenyl]phenyl]pyrazole-3,5-dicarboxamide	Investigative	50925404	C19H12F6N4O2	442.3	C1=CC(=CC(=C1)N2C(=CC(=N2)C(=O)N)C(=O)N)C3=C(C=CC(=C3)C(F)(F)F)C(F)(F)F	IC50 = 2000000 nM	Non binder
T43739	Voltage-gated sodium channel alpha Nav1.8	BJ14TI	1-[3-[2-(Trifluoromethoxy)-5-(trifluoromethyl)phenyl]phenyl]pyrazole-3,5-dicarboxamide	Investigative	53321263	C19H12F6N4O3	458.3	C1=CC(=CC(=C1)N2C(=CC(=N2)C(=O)N)C(=O)N)C3=C(C=CC(=C3)C(F)(F)F)OC(F)(F)F	IC50 = 1181000 nM	Non binder